Senseonics Holdings (SENS) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Senseonics Holdings, Inc. Reports Second Quarter 2017 Financial Results
August 9, 2017 4:15 PM EDTGERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the second quarter ended June 30, 2017.
RECENT HIGHLIGHTS & ACCOMPLISHMENTS:
Expanded commercialization of Eversense System from four to seven European countries Announced collaboration with Roche Diabetes and TypeZero to develop an Automated Insulin Delivery system Completed financing of $40.4 million led by Roche Finance Ltd.... More